Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Plasmidsaurus offers rapid whole-plasmid and viral vector genome sequencing using advanced nanopore-based technologies. Their services eliminate the need for primers or manual minipreps and deliver high-quality annotated results within days. The company’s new AAV genome service enables full-length vector analysis with low input requirements—benefiting gene therapy R&D by providing fast insight into capsid contents. Their customer base includes academic labs, biotech startups, pharmaceutical companies, CDMOs, and DIY biohackers worldwide. No clinical results as they do not develop therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Plasmidsaurus.